<?xml version="1.0" encoding="UTF-8"?>
<p>The sample size was calculated by examining other products of rhG-CSF. From reviews of recently developed rhG-CSF products,
 <xref rid="b12-dddt-12-2381" ref-type="bibr">12</xref>–
 <xref rid="b14-dddt-12-2381" ref-type="bibr">14</xref> the intra-subject coefficients of variations (CV
 <sub>w</sub>) of AUC
 <sub>inf</sub> and 
 <italic>C</italic>
 <sub>max</sub> of filgrastim were 15.6%–20.29% and 13.64%–23.94%, respectively. Based on the data, using the greatest CV
 <sub>w</sub>, 23.94%, at a significance level of 0.05 with 80% power, the required sample size was calculated to be 11 subjects/group using a modified Hauschke's equation.
 <xref rid="b15-dddt-12-2381" ref-type="bibr">15</xref> Using an assumption of a 20% dropout rate, the required sample size was 28 subjects/dosing part, to give 56 subjects in total.
</p>
